TUSTIN, Calif., March 12 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc.

Arius Research has entered into a manufacturing supply and technology transfer agreement for its CD44 cancer stem cell antibody with Avid Bioservices, a company providing cGMP manufacturing services.